Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

120. Dr. Feldman on MENTAL ACCOUNTING - Avapritinib for systemic mastocytosis - IL-17-blockers: smaaaaall risk of IBD - Dermasphere clip show: Episodes 111-119!

120. Dr. Feldman on MENTAL ACCOUNTING - Avapritinib for systemic mastocytosis - IL-17-blockers: smaaaaall risk of IBD - Dermasphere clip show: Episode…

FromDermasphere - The Dermatology Podcast


120. Dr. Feldman on MENTAL ACCOUNTING - Avapritinib for systemic mastocytosis - IL-17-blockers: smaaaaall risk of IBD - Dermasphere clip show: Episode…

FromDermasphere - The Dermatology Podcast

ratings:
Length:
65 minutes
Released:
Dec 11, 2023
Format:
Podcast episode

Description

Dr. Feldman on MENTAL ACCOUNTING -
Avapritinib for systemic mastocytosis -
IL-17-blockers: smaaaaall risk of IBD -
Dermasphere clip show: Episodes 111-119! -
Want to donate to the cause? Do so here! http://www.uofuhealth.org/dermasphere
Check out our video content on YouTube: https://www.youtube.com/@dermaspherepodcast
and VuMedi!: https://www.vumedi.com/channel/dermasphere/
The University of Utah's Dermatology ECHO: ⁠⁠https://physicians.utah.edu/echo/dermatology-primarycare -
⁠⁠Connect with us!
- Web: ⁠https://dermaspherepodcast.com/⁠
- Twitter: @DermaspherePC
- Instagram: dermaspherepodcast
- Facebook: https://www.facebook.com/DermaspherePodcast/
- Check out Luke and Michelle’s other podcast, SkinCast! ⁠https://healthcare.utah.edu/dermatology/skincast/⁠
Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:
- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)
- ⁠https://www.levelex.com/games/top-derm⁠ (A free dermatology game to learn more dermatology!)
Released:
Dec 11, 2023
Format:
Podcast episode

Titles in the series (100)

For dermatology practitioners, Dermasphere covers the most important updates from the latest articles and research in the field. Maybe you don’t have time to read the journals—but we hope you have time to listen to a podcast about them!